Evidence map›Paper›PMID 40261068›Full record

ArticleAntimicrobial agents and chemotherapy2025

Gametocyte production and transmission fitness of African and Asian

Nicholas I Proellochs, Chiara Andolina, Jordache Ramjith, Rianne Stoter, Geert-Jan van Gemert, Wouter Graumans, Susana Campino, Leen N Vanheer, Martin Okitwi, Patrick K Tumwebaze and 6 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Nicholas I ProellochsDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.ORCID 0000-0003-3750-1135
Chiara AndolinaDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Jordache RamjithDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Rianne StoterDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Geert-Jan van GemertDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Wouter GraumansDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Susana CampinoDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Leen N VanheerDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Martin OkitwiInfectious Diseases Research Collaboration, Kampala, Uganda.
Patrick K TumwebazeInfectious Diseases Research Collaboration, Kampala, Uganda.
Melissa D ConradDepartment of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0002-9984-8030
Taane G ClarkDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0001-8985-9265
David A FidockDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York, USA.
Didier MénardMalaria Parasite Biology and Vaccines Unit, Institut Pasteur, Université Paris Cité, Paris, Île-de-France, France.
Sachel MokCenter for Malaria Therapeutics and Antimicrobial Resistance, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, USA.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.ORCID 0000-0003-2666-094X

Funding

Defining P. falciparum resistance to artemisinin-based combination therapiesR01AI109023 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FIDOCK, DAVID A · 2014 to 2025
$4.4M
Surveillance to track and characterize antimalarial resistance trends in Ugandan Plasmodium falciparum parasites (STARTUP)R01AI173557 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Melissa D Conrad · 2023 to 2026
$2.9M
The genetic basis of emerging multidrug resistance in Plasmodium falciparum African malariaR01AI182318 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sachel Mok · 2024 to 2026
$1.9M
NIAID NIH HHS R01 AI109023NIAID NIH HHS R01 AI173557NIAID NIH HHS R01 AI182318
6 · The paper itself

Abstract

The emergence of

Indexed as

AntimalarialsArtemisininsMalaria, FalciparumPlasmodium falciparumAfricaAnimalsAnophelesDrug ResistanceGenotypeHumansMosquito VectorsAntimalarialsartemisininArtemisininsartenimolartemisinin resistanceK13 genotypemalariamosquito transmissionP. falciparum

Identifiers

PMID40261068
PMCPMC12135531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.